bm-navigation: bm-t1-home-navigation-1
bm-pageheader: bm-t2-aboutus-pageheader

FierceBiotech – Biotech HiberCell launches with $60M+ to combat cancer relapse and metastasis

FierceBiotech – Biotech HiberCell launches with $60M+ to combat cancer relapse and metastasis

HiberCell, a new startup focused on preventing cancer metastasis and relapse, launched Thursday with research out of Mount Sinai and $60.75 million from the likes of ARCH Venture Partners, Hillhouse Capital and 6 Dimensions Capital.

Read full story by Amirah Al Idrus here.